Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Skillz Plays the Game of Growth, But It’s Not a Buy Here

By Stavros Georgiadis, CFA, InvestorPlace Contributor
“The future of sports is electronic. The future of sports is mobile. The future of sports is now.” This is what Skillz Inc. (NYSE:SKLZ) says…

3 Gig Worker Stocks to Sell After Uber’s Latest Stumble

By Joel Baglole, InvestorPlace Contributor
Shares of ride hailing and food delivery company Uber Technologies have hit the skids. A judge in California recently struck down Proposition 22, a ballot initiative that exempted Uber from classifying its drivers as full-time employees. The ruling means that Uber and other gig economy companies could now be forced to provide the people who work for them with a minimum wage, overtime pay, workers' compensation, and the right to unionize.

Don’t Buy Into the Alibaba Stock Pullback Story

By Steve Booyens, CFA
BABA stock is depleted due to both systemic and fundamental matters. It's very unlikely that this is an opportunity to buy the dip.

Nvidia Stock Is on the Verge of Extended Disappointment

By Tom Kerr, InvestorPlace Contributor
At these high valuations, NVDA stock gains will be limited to market averages going forward, but they will eventually break free.

Roblox Stock Is Overpriced and Faces Tough Upcoming Challenges

By Muslim Farooque, InvestorPlace Contributor
RBLX stock faces reopening headwinds and its unreasonable valuation makes it a lackluster investment at this point

There’s More Bad News Than Good News Ahead for Workhorse Stock

By Stavros Georgiadis, CFA, InvestorPlace Contributor
Workhorse has a chance to disrupt the electric vehicle industry, but it requires tons of urgent improvements before WKHS stock is buy-worthy.

Context Logic Had a Disastrous Q2, and Q3 Could Be Even Worse

By Muslim Farooque, InvestorPlace Contributor
The cracks in Wish Stock 's business model have become apparent with its recent dismal second quarter results

7 Oil Stocks to Sell for September

By Louis Navellier and the InvestorPlace Research Staff
While this certainly isn't 2020, the economy continues to deal with the pandemic and there's no better example than these oil stocks.

As Fears of the Delta Variant Subside, Pinterest Looks Unattractive

By Larry Ramer, InvestorPlace Contributor
Data indicates that the economic reopening is hurting Pinterest. As a result, PINS stock is unappealing at its current levels.

Jumia Has Great Potential, But Avoid It For Now

By Alex Sirois, InvestorPlace Contributor
JMIA stock has declined in 2021 after starting hot. The future still is full of potential. but it's unlikely to materialize right now.

Is the Juice Worth the Squeeze in Clover Health Investments Stock?

By Chris Markoch, InvestorPlace Contributor
CLOV stock looks to be setting up for a short squeeze. But that runs the risk of papering over the obstacles that Clover Health needs to overcome.

3 New Reasons To Sell Robinhood Now

By Wayne Duggan, InvestorPlace Contributor
Robinhood put up some extremely impressive growth numbers in the second quarter. But that growth won't last, and HOOD stock is a huge gamble.

The Odds Are Firmly Against Ocugen Stock Now

By Muslim Farooque, InvestorPlace Contributor
OCGN stock is a remarkably risky Covid-19 vaccine play, as the company faces a myriad of regulatory roadblocks on different fronts.

Clover Health: Insurance Losses Lead to Anemic Stock Price

By Ian Bezek, InvestorPlace Contributor
Clover Health has been a disappointing situation all year long. And things went from bad to worse for CLOV stock following dour Q2 earnings.

Zomedica Needs to Start Delivering Tangible Results

By Ian Bezek, InvestorPlace Contributor
Zomedica has an interesting story that could work out. However, the company's inability to execute is raising key concerns about ZOM stock.

Carnival Stock Continues to Carry Weight of the ‘Unwanted’ Passenger

By Will Ashworth, InvestorPlace Contributor
Carnival’s customers are still getting Covid-19 on its ships. That's not good news for CCL stock. At this point, buyers should beware. 

Square Stock Is so Much More Vulnerable as It Adds Even More Credit Risk

By Dana Blankenhorn, InvestorPlace Contributor
With a credit card, the risk is on the bank. With Buy Now, Pay Later, it's on the merchant. Those predicting Square will soon outrun JPMorgan Chase aren't accounting for those risks.

Novavax Is Selling a Dream, But You Should Live in Reality

By Stavros Georgiadis, CFA, InvestorPlace Contributor
The price of NVAX stock reflects hope in the company's Covid-19 vaccine, but hope doesn't change their poor fundamentals.

DiDi Stock Could Drop by Two-Thirds if the Company Leaves China

By Mark R. Hake, CFA
DiDi's Chinese business has been gutted by regulators removing its app from app stores, which is terrible news for DIDI stock.
Load More Articles